CORE Diagnostics receives International Accreditation from College of American Pathologists (CAP), Health News, ET HealthWorld

India, 9th June 2021: CORE Diagnostics, a NABL accredited, Gurgaon-based high-end clinical laboratory, has recently received an accreditation certification from the College of American Pathologists (CAP), a leading international laboratory accrediting organization, based on the results of a recent assessment as part of the CAP’s Accreditation Programs.

Commenting on the accomplishment, Dinesh Chauhan, CEO, CORE Diagnostics, said, “We are extremely proud to join the ranks of the most elite laboratories in the world, and our team behind this deserves all the accolades. This is another step in our company’s expansion plans and towards offering best-in-class diagnostic accuracy while complying with rigorous criteria of quality assurance to all.”

“This marks yet another testament of the excellence and expertise we hold.”

The CAP laboratory accreditation program is recognized by U.S. federal government as equal to or more-stringent-than the government’s own inspection program. CORE Diagnostics becomes one of the nearly 8,000 CAP-accredited facilities worldwide and one of only fourteen standalone labs in India. This certification by CAP accredits a whole range of tests that includes diagnosis in fields like cardiology, oncology, endocrinology, infectious diseases, gynaecology, and nephrology.

“CORE Diagnostics demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,” said Richard Scanlan, MD, FCAP, chair of the CAP’s Council on Accreditation that oversees the program. “The CAP congratulates CORE Diagnostics on its recent CAP Accreditation.”

On this occasion, Dr. Shivani Sharma, Lab Director, shared – “We are extremely proud about this achievement. Being certified by CAP is a reflection of our commitment to the highest standards of quality in diagnostic testing to our clinicians, hospitals & patients.”

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.